Punjab Chemicals & Crop Protection Limited — Q1 FY26 earnings call

Call held 29 Jul 2025

Management summary

Punjab Chemicals delivered a strong Q1 FY26 with significant revenue and profit growth, driven by market recovery and new product introductions. Despite a dip in gross margins due to strategic inventory build-up, management expects recovery in subsequent quarters. The company is investing INR60 crores in brownfield expansion and planning a larger INR250 crore greenfield project to support future growth and portfolio diversification.

Highlights

  • Revenue of INR319.5 crores, up 31.9% YoY, driven by robust domestic and export momentum.

  • EBITDA of INR34.4 crores, up 24.5% YoY, supported by volume growth and product mix.

  • PAT of INR20.63 crores, up 52.8% YoY, with PAT margins improving by 90 bps to 6.5%.

  • Strategic investment of INR60 crores for new manufacturing blocks and debottlenecking, expected to contribute INR100-150 crores in sales over 2-3 years.

  • Successful commercialization of one new herbicide in Q1, enriching the product portfolio.

Concerns

  • EBITDA margins for the quarter stood at 10.8%, down from 11.4% in the same period last year.

  • Gross margins at 33.1%, lowest in 15-16 quarters, attributed to higher closing stock from Q4 FY25.

  • Excess capacity continues to be a challenge in the agrochemical industry.

  • Pricing has stabilized at the bottom but significant improvement is yet to be seen, though 5-10% improvement is expected towards year-end.

Key financials

  1. Revenue ₹319.5 Cr +31.9%YoY
  2. Gross Margin 33.1%
  3. EBITDA ₹34.4 Cr +24.5%YoY
  4. EBITDA Margin 10.8%
  5. PAT ₹20.63 Cr +52.8%YoY
  6. PAT Margin 6.5%
  7. Domestic Revenue ₹196 Cr
  8. International Revenue ₹123 Cr
  9. Working Capital Cycle 107 days

What they filed

Q1 FY27: revenue up 8.5%, net profit up 10.0% against the same quarter last year.

₹ Cr · quarterly
Line itemQ2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue242 214 201 319 254 +5%246 +15%207 +3%346 +8%
EBITDA26 20 25 34 25 −4%29 +45%27 +8%41 +21%
Net profit12 7 7 20 17 +42%14 +100%10 +43%22 +10%
How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Segment breakdown

  • Agrochemical division (Derabassi)
    79% Capacity Utilization
  • Performance Chemicals division (Lalru)
    70% Capacity Utilization
  • Industrial Chemical division (Pune)
    100% Capacity Utilization

Capital allocation

high confidence
  • Capex ₹250 Cr
    • Strategic investment for expansion, new manufacturing blocks, and debottlenecking existing capacities ₹60 Cr
    • Greenfield project for new integrated facility (including land acquisition) ₹250 Cr
    • Doubling R&D physical setup and adding new people
    In line with this, we are pleased to announce a strategic investment of approximately INR60 crores to expand and cater to business growth for global market. This capital expenditure will involve construction of new manufacturing blocks and also debottlenecking of certain capacities at our existing facility. The balance investment that we had projected was to start with a greenfield project, where obviously land acquisition costs will be a significant cost, followed by the -- all the approvals and then investment in the new facility that we are planning to planning in an integrated facility. So that plan for investing about INR250 crores over the next 3 years remains intact. Sir, physical setup will be double of the existing site, whatever we have. So that expansion is already in progress. And also because in order to get the increased physical setup, we are adding new people continuously.

Guidance & targets

Revenue

  • Revenue Growth Revenue · FY26 · High confidence 20%
    I think we stick to the number of 20% forecast for the year. And yes, obviously, we are putting efforts to do better, but I think that we keep our forecast at a conservative number of around 20%.

    — Vinod Gupta

  • Revenue Growth (potential) Revenue · FY26 · Medium confidence 25-28%
    So as and when the registrations take place, the product volume will increase, that will in turn increase our from 20%, we can go to 25% to 28%.

    — Shalil Shroff

New Product Sales

  • Sales from INR60cr capex products New Product Sales · next 2-3 years · High confidence INR100-150 crores
    The expansion planned over the next 2 years is expected to contribute anywhere close to INR100 crores to INR150 crores in sales over the next 2 to 3 years.

    — Vinod Gupta

Gross Margin

  • Gross Margin Gross Margin · Q2/Q3 FY26 · High confidence 37-39%
    And even as we see for the Q2, Q3, we'll be back at the margins, which we are between 37% to 39%.

    — Shalil Shroff

  • Gross Margin Gross Margin · next financial year (FY27) · Medium confidence 16-18%
    And as we also have mentioned that moving forward, the new products which are coming in where the margins are good. So hoping that for the next financial year, that is '26, '27, we should be between that 16% and 18%.

    — Shalil Shroff

New Product Launches

  • Number of new products New Product Launches · FY26 · High confidence minimum 5
    I think, I mean, we had indicated in the last quarter presentation that this year, we'll be commercializing at least five products. So we are on track to commercialize minimum five products.

    — Vinod Gupta

Specialty Chemical Sales

  • Sales from specific Specialty Chemical product (Europe) Specialty Chemical Sales · next 2-3 years · High confidence INR30-40 crores
    And we expect this product to give us a top line of about INR30 crores to INR40 crores over the next 2 to 3 years every year. So this year, again, our volumes are going to be double of what we have done last year.

    — Vinod Gupta

Capacity Utilization

  • Peak Revenue at existing capacity Capacity Utilization · per quarter · Medium confidence INR300-350 crores
    But at current assume that the price levels are what they are currently, from our existing assets, we can do every quarter with an optimum capacity utilization roughly about INR300 crores to INR350 crores per quarter.

    — Vinod Gupta

Capex

  • New Manufacturing Block Commercialization Capex · Q3 FY27 · High confidence Q3 of next financial year
    Block should kick in from Q3 of the next financial year.

    — Vinod Gupta

R&D

  • R&D Setup Expansion R&D · current year · High confidence doubling
    Sir, physical setup will be double of the existing site, whatever we have. So that expansion is already in progress.

    — Vinod Gupta

Employee Cost

  • Employee Cost as % of Revenue Employee Cost · ongoing · High confidence 7-8%
    So you can take anywhere between 7% to 8% is where we are targeting. But yes, on a higher side, we have never crossed 10%. So we'll try and fix it up within that range. So a good scenario would be about 8% to 9%, but yes, we will restrict ourselves to about 10%.

    — Vikash Khanna

What to watch in Q2 FY26

Gross Margin Recovery

Q2/Q3 FY26
Current 33.1%
Target 37-39%

Why it matters

Gross margin compression was a key concern this quarter; its recovery is crucial for profitability.

And even as we see for the Q2, Q3, we'll be back at the margins, which we are between 37% to 39%.

Risks & concerns

  • Excess capacity in agrochemical industry

    medium

    Excess capacity continues to be a challenge in the agrochemical industry, but the company focuses on quality and cost to maintain market share.

    Management acknowledged

  • Pricing pressure

    medium

    Prices have stabilized at the bottom, but significant improvement is yet to be seen, though 5-10% improvement is expected towards the end of the financial year.

    Management acknowledged

  • Greenfield project delays

    medium

    Management acknowledged some delay in finalizing the new greenfield site but is actively scouting for the right opportunity and working hard on it.

    Management acknowledged

Q&A highlights

7 direct
Inventory Buildup and Gross Margin Impact Direct
Now one of the reasons for this margin was that we had a higher closing stock in the previous quarter. We anticipated that there was a good market in the coming quarter. So as a result, we created an inventory. We built up an inventory. Now as you know that the inventory is normally valued at cost in the books, whereas when you actually realize those inventory, they are at the selling price. So obviously, there was a higher cost factor, which was involved in the closing stock. It finally got diluted in form of sales in the coming quarter. So that was the reason why the percentage is a little lower. It gets ironed out in subsequent quarters.

Explains the primary reason for the lower gross margins in Q1 despite strong revenue growth, attributing it to a strategic inventory build-up and its accounting impact.

Asked by Jatin Damania

Receivables and Working Capital Cycle Direct
So see, the net working capital cycle, which we had in FY '25 was 111 days, which has come down to about 107 days, which means that the company has higher amount of capital tied in the business operation. The capital is being utilized for running the business efficiently.

Provides an update on the company's working capital management and efficiency, showing a slight improvement.

Asked by Jatin Damania

Greenfield Project Timeline and Status Partial
See, I think we are continuously looking for a good option. And we want to look for a greenfield project, which can actually take care of our business needs for next 4 to 5 years. I think as announced in earlier con-calls, we have shortlisted a few locations. There are some -- we are at an advanced stage of discussions. But at the same time, because we have some space available in existing sites, we are looking to acquire at the right time so that we put capital and don't block it for a longer period. So yes, I think we are actually scouting for the right opportunity. And that's why I think you will probably have seen some delay, but I think we are working hard on it.

Addresses the status of a significant long-term growth initiative (INR250 crore greenfield project), acknowledging delays but reaffirming commitment to finding the right opportunity.

Asked by Jatin Damania

Brownfield vs. Greenfield Capex Details Direct
So I think currently, the new manufacturing block that we are talking about and some debottlenecking of capacities will be commercialized in the next 12 to 18 months. And that's an immediate future that we can clearly see because based on our product pipeline and the demand that we are seeing. The balance investment that we had projected was to start with a greenfield project, where obviously land acquisition costs will be a significant cost, followed by the -- all the approvals and then investment in the new facility that we are planning to planning in an integrated facility. So that plan for investing about INR250 crores over the next 3 years remains intact.

Clarifies the distinction and timelines for the announced INR60 crore brownfield capex (near-term) and the larger INR250 crore greenfield capex (long-term).

Asked by Rahul Jain

Gross Margin Fall and Product Mix Explanation Direct
So when I say product mix no, I think when we are saying product mix, what we meant was a strategic decision taken to utilize the capacity in Q4 when the demand is low and carry forward that inventory in this quarter. I think that's what we meant by product mix. And even as we see for the Q2, Q3, we'll be back at the margins, which we are between 37% to 39%.

Reiterates the reason for the Q1 gross margin dip, clarifying it as a strategic inventory decision rather than a fundamental product mix issue, and provides clear guidance on margin recovery.

Asked by Rahul Jain

Peak Revenue at Existing Capacity Direct
I think, I mean, obviously, peak revenue is dependent on the product mix, market demand, product pricing because there are so many variables. But at current assume that the price levels are what they are currently, from our existing assets, we can do every quarter with an optimum capacity utilization roughly about INR300 crores to INR350 crores per quarter.

Provides a quantitative estimate of the company's maximum revenue potential with its current asset base, setting a benchmark for future growth from new capacities.

Asked by Rudraksh Raheja

Sustainability of Q1 Performance and FY26 Growth Outlook Direct
I think our initial signals what we are getting in the Q1 is indicating that we will have that kind of a growth in this year where demand is healthy. And our forecast from most of our markets and customers is looking very, very good and very bullish. So I think we should be growing existing product also anywhere from 10% to 15% during this financial year. I think we expect the momentum to continue in this year.

Confirms management's confidence in the sustainability of the strong Q1 performance and reiterates the positive outlook for FY26 growth, supported by healthy demand.

Asked by Ankit Gupta

Export Market Conditions and Pricing Trends Direct
I think as far as export market is concerned, Europe demand is healthy this year. So I think that's a very positive sign because a lot of our products are focused on Europe. Japan market demand is also stable. So we don't see a challenge from Japan market also. There is obviously some challenge, which is coming from Latin America market, where some of our products go to that market. But I think that is being offset by the demand that is coming from Rest of the World. I think this year, we'll reach FY '24 levels on exports market. I think we don't see and maybe it will be slightly higher, but we'll at least go back to the same levels. Please keep in mind, I think when the earlier high number was there, that time prices were much higher. So in fact, this year, volumes will be much higher, but the prices are lower. So overall, our market share and the demand is looking healthy that way. But gradual improvement in the prices is clearly -- will be visible because I think the profitability based on current prices is not great for most of the players. So gradually, you should see some improvement, maybe 5%, 10% towards the end of this financial year.

Provides a detailed overview of demand and pricing trends across key export geographies, highlighting recovery in Europe/Japan and expectations for price improvement towards year-end.

Asked by Ankit Gupta

2 min read 6 chapters

Detailed narrative

Q1 FY26 Financial Performance Highlights

Punjab Chemicals reported a strong Q1 FY26, with revenue reaching INR319.5 crores, marking a 31.9% year-on-year growth. This performance was driven by robust momentum in both domestic and export markets. EBITDA for the quarter stood at INR34.4 crores, reflecting a 24.5% year-on-year growth, while PAT surged by 52.8% to INR20.63 crores. PAT margins improved by 90 basis points year-on-year to 6.5%.

Strategic Investments and Capacity Expansion

The company announced a strategic investment of approximately INR60 crores for expanding manufacturing capacity, which includes constructing new manufacturing blocks and debottlenecking existing facilities. This brownfield expansion is expected to contribute INR100-150 crores in sales over the next 2-3 years, with commercialization anticipated in Q3 FY27. Additionally, Punjab Chemicals is actively evaluating a new site for a larger greenfield project, with a planned capital expenditure of INR250 crores over the next 3-4 years, aiming for an integrated facility to support long-term growth.

Gross Margin Dynamics and Outlook

Gross margins for Q1 FY26 were 33.1%, lower than the historical range of 37-40%. Management attributed this to a strategic decision in Q4 FY25 to build inventory at cost, anticipating strong Q1 demand, which then impacted Q1 margins upon sale. They assured that gross margins are expected to recover to 37-39% in Q2 and Q3 FY26, and to reach 16-18% for the next financial year, driven by a favorable product mix and new, higher-margin products.

Product Portfolio Expansion and R&D Focus

Punjab Chemicals successfully commercialized one new herbicide in Q1 FY26, further enriching its product portfolio. The company plans to launch a minimum of five new products in FY26, with a robust pipeline for commercialization over the next 2-3 quarters. R&D efforts are being significantly strengthened, with plans to double the physical setup and headcount, focusing on innovation, yield improvement, and developing novel chemistries for specialty chemicals.

Market Conditions and Demand Outlook

The agrochemical industry is showing early signs of recovery, with normalized inventory levels and halted price declines. Favorable monsoon and higher reservoir levels have created positive market sentiments. Demand for flagship products has revived, and the company expects to achieve a conservative revenue growth of 20% for FY26, with potential to reach 25-28%. Export markets, particularly Europe and Japan, are showing healthy demand, offsetting some challenges in Latin America.

Operational Efficiency and Working Capital Management

The company demonstrated strong capacity utilization across its sites, with the Agrochemical division at 79%, Performance Chemicals at 70%, and Industrial Chemical division operating at full capacity. The net working capital cycle improved to 107 days in Q1 FY26, down from 111 days in FY25, indicating more efficient capital utilization. Employee cost as a percentage of revenue was 8% in Q1, with a target to maintain it between 7-8% and restrict it to 10%.

This is an AI-generated summary of a publicly available earnings call transcript.
View original transcript

More Chemicals earnings calls